Lookup NU author(s): Dr Anna Luce,
Professor Ian McKeith
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the drug. (C) 2001 Movement Disorder Society.
Author(s): McKeith IG; Luce AK; Reading PJ
Publication type: Article
Publication status: Published
Journal: Movement Disorders
ISSN (print): 0885-3185
ISSN (electronic): 1531-8257
Publisher: John Wiley & Sons
Altmetrics provided by Altmetric